PositiveReview/Other2016
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose.
Classification Results
AI Classification
PositiveFine-tuned Classification
PositiveAI Classification
PositiveFine-tuned Classification
PositivePossible Anxiolytic Effects of Cannabidiol (CBD) Administration on Feline Responses to a Fear Response Test
Critical Windows of Vulnerability: Behavioral Dysregulation After Prenatal vs. Adolescent THC Exposure
Recreational drugs repurposed for medicinal use—cannabis
Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances
Specific features of cannabidiol metabolism and excretion during long-term consumption of cannabis
Role of Lupinus Arboreus Extract in Cannabis-Induced Psychotic Behaviors in Wistar Rats